FrancophonIA/ELRC3.0 huggingface dataset:
English: In the second study the average increase in FEV1 was 140 ml more with Xoterna Breezhaler than with treatment with fluticasone and salmeterol.
Danish: I den anden undersøgelse var den gennemsnitlige stigning i FEV1 140 ml større med Xoterna Breezhaler end med fluticason og salmeterol.
English: Other information about Xoterna Breezhaler
Danish: Andre oplysninger om Xoterna Breezhaler
English: What is Xoterna Breezhaler and what is it used for?
Danish: Hvad er Xoterna Breezhaler, og hvad anvendes det til?
English: It is not intended to provide practical advice on how to use Xoterna Breezhaler.
Danish: Det er ikke en praktisk vejledning i, hvordan Xoterna Breezhaler bør anvendes.
English: Why is Xoterna Breezhaler approved?
Danish: Hvorfor er Xoterna Breezhaler blevet godkendt?
English: For practical information about using Xoterna Breezhaler, patients should read the package leaflet or contact their doctor or pharmacist.
Danish: Hvis du ønsker praktisk vejledning i anvendelsen af Xoterna Breezhaler, kan du læse indlægssedlen eller kontakte din læge eller dit apotek.
English: Xoterna Breezhaler is available as capsules containing a powder for inhalation can only be obtained with a prescription.
Danish: Xoterna Breezhaler leveres som inhalationspulver i kapsler og udleveres kun efter recept.
English: For the full list of all side effects reported with Xoterna Breezhaler, see the package leaflet.
Danish: Den fuldstændige liste over indberettede bivirkninger ved Xoterna Breezhaler fremgår af indlægssedlen.
English: What are the risks associated with Xoterna Breezhaler?
Danish: Hvilken risiko er der forbundet med Xoterna Breezhaler?
English: A third study studied the effects of Xoterna Breezhaler on the rate of exacerbations (flare-ups) patients experienced during 64 weeks of treatment when compared with treatment with glycopyrronium or tiotropium (other treatments for COPD).
Danish: En tredje undersøgelse vedrørte virkningerne af 64 ugers behandling med Xoterna Breezhaler på andelen af tilbagefald, sammenlignet med glycopyrronium eller tiotropium (andre midler mod KOL).
English: How is Xoterna Breezhaler used?
Danish: Hvordan anvendes Xoterna Breezhaler?
English: Muscarinic receptor antagonists and long-acting beta-2-adrenergic agonists are commonly combined in the management of COPD.
Danish: Det er almindeligt at behandle KOL med en kombination af muskarine receptorantagonister og langtidsvirkende beta-2-adrenerge agonister.
English: What benefits of Xoterna Breezhaler have been shown in studies?
Danish: Hvilke fordele viser undersøgelserne, at der er ved Xoterna Breezhaler?
English: While one study compared the effects of Xoterna Breezhaler with those of placebo (a dummy treatment), or indacaterol or glycopyrronium alone, the other study compared Xoterna Breezhaler with fluticasone plus salmeterol, a standard treatment for COPD.
Danish: Den ene undersøgelse sammenlignede virkningerne af Xoterna Breezhaler med virkningerne af placebo (en virkningsløs behandling) eller med indacaterol eller glycopyrronium alene.
English: How does Xoterna Breezhaler work?
Danish: Hvordan virker Xoterna Breezhaler?
English: Further information on Vyxeos can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Danish: Yderligere information vedrørende Vyxeos findes på agenturets websted under: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: They interfere in different ways with the production of new DNA within cells, which means the cells are unable to grow and multiply, and they eventually die.
Danish: De griber på forskellige måder ind i produktionen af nyt dna i cellerne, og det betyder, at cellerne ikke kan vokse og formere sig, og til sidst dør de.
English: Other information about Vyxeos
Danish: Andre oplysninger om Vyxeos
English: As for all medicines, data on the use of Vyxeos are continuously monitored.
Danish: Som for alle lægemidler bliver data vedrørende brugen af Vyxeos løbende overvåget.
English: The side effects were similar to the known side effects of the active substances and were considered manageable.
Danish: Bivirkningerne var de samme som de kendte bivirkninger ved de aktive stoffer og vurderes at være håndterbare.
English: What measures are being taken to ensure the safe and effective use of Vyxeos?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af Vyxeos?
English: For more information about using Vyxeos, see the package leaflet or contact your doctor or pharmacist.
Danish: For mere information om brug af Vyxeos, se indlægssedlen eller kontakt lægen eller apotekspersonalet.
English: The most common side effects with Vyxeos (which may affect more than 1 in 5 people) are hypersensitivity (allergic reactions, especially rash), febrile neutropenia (low white cell counts with fever), oedema (swelling), diarrhoea, colitis (inflamed bowel), mucositis (inflammation of the moist body surfaces), tiredness, muscle and bone pain, belly pain, decreased appetite, cough, headache, chills, arrhythmias (irregular heart rhythm), fever, sleep disorders and hypotension (low blood pressure).
Danish: De hyppigste bivirkninger ved Vyxeos (der kan forekomme hos mere end 1 ud af 5 patienter) er overfølsomhed (allergiske reaktioner, navnlig udslæt), febril neutropeni (lavt antal hvide blodlegemer med feber), ødem (hævelse), diarré, colitis (tyktarmsbetændelse), mucositis (slimhindebetændelse), træthed, muskel- og knoglesmerter, mavesmerter, nedsat appetit, hoste, hovedpine, kulderystelser, arytmier (uregelmæssig hjerterytme), feber, søvnforstyrrelser og hypotension (lavt blodtryk).
English: The European Medicines Agency decided that Vyxeos's benefits are greater than its risks and it can be authorised for use in the EU.
Danish: Det Europæiske Lægemiddelagentur konkluderede, at fordelene ved Vyxeos opvejer risiciene, og at det kan godkendes til anvendelse i EU.
English: Vyxeos (daunorubicin / cytarabine) EMA/457184/2018
Danish: Vyxeos (daunorubicin/cytarabin) EMA/457184/2018
English: Some 34% of patients given Vyxeos (52 of 153) were able to go on to have a stem cell transplant (a potentially curative procedure where the patient's bone marrow is replaced by stem cells to form new, healthy bone marrow) compared with 25% (39 of 156) given conventional treatment.
Danish: Ca. 34 % af de Vyxeos-behandlede patienter (52 ud af 153) kunne efterfølgende få foretaget stamcelletransplantation (en potentielt helbredende procedure, hvor patientens knoglemarv erstattes med stamceller, der skal danne ny, sund knoglemarv), sammenholdt med 25 % af de patienter, der fik konventionel behandling (39 ud af 156).
English: Side effects reported with Vyxeos are carefully evaluated and any necessary action taken to protect patients.
Danish: Bivirkninger rapporteret for Vyxeos vurderes omhyggeligt, og der tages de nødvendige forholdsregler for at beskytte patienterne.
English: An overview of Vyxeos and why it is authorised in the EU
Danish: En oversigt over Vyxeos, og hvorfor det er godkendt i EU
English: Vyxeos can only be obtained with a prescription and treatment should be started and supervised by a doctor experienced in using cancer medicines.
Danish: Vyxeos udleveres kun på recept, og behandlingen skal påbegyndes og overvåges af en læge med erfaring i brug af kræftmedicin.
English: Vyxeos (daunorubicin / cytarabine)
Danish: Vyxeos (daunorubicin/cytarabin)
English: What is Vyxeos and what is it used for?
Danish: Hvad er Vyxeos, og hvad anvendes det til?
English: The doctor may delay doses or stop treatment if the patient has severe side effects.
Danish: Lægen kan beslutte at udskyde doserne eller helt stoppe behandlingen hos patienter, som får svære bivirkninger.
English: Why is Vyxeos authorised in the EU?
Danish: Hvorfor blev Vyxeos godkendt i EU?
English: Patients given Vyxeos lived on average around 9.6 months after treatment, whereas those given conventional cytarabine and daunorubicin lived about 6 months.
Danish: Patienter, der fik Vyxeos, levede i gennemsnit ca. 9,6 måneder efter behandlingen, mens dem, der fik konventionel cytarabin og daunorubicin, levede i ca. 6 måneder.
English: The liposomes protect the cancer medicines from being broken down early, which is expected to enhance their effect on cancer cells.
Danish: Liposomerne beskytter kræftmedicinen mod at blive nedbrudt for hurtigt, hvilket forventes at forbedre medicinens effekt på kræftcellerne.
English: The liposomes are expected to remain in the patient's body for longer than conventional cytarabine and daunorubicin medicines and to build up in the patient's bone marrow.
Danish: Det forventes, at liposomerne bliver i patientens krop i længere tid end konventionelle cytarabin- og daunorubicin-lægemidler og ophobes i patientens knoglemarv.
English: What are the risks associated with Vyxeos?
Danish: Hvilke risici er der forbundet med Vyxeos?
English: The active substances in Vyxeos, cytarabine and daunorubicin, have been used together to treat leukaemia and other types of cancer for many years.
Danish: De aktive stoffer i Vyxeos, cytarabin og daunorubicin, har været anvendt til behandling af leukæmi og andre kræftsygdomme i mange år.
English: The study compared Vyxeos with conventional cytarabine and daunorubicin infusions.
Danish: Studiet sammenlignede Vyxeos med konventionelle cytarabin- og daunorubicin-infusioner.
English: Vyxeos is given by infusion (drip) into a vein.
Danish: Vyxeos gives som infusionsvæske (drop) i en blodåre.
English: In this medicine, cytarabine and daunorubicin are contained in tiny fat droplets called ‘liposomes'.
Danish: I dette lægemiddel indeholdes cytarabin og daunorubicin i bittesmå fedtdråber, der kaldes liposomer.
English: Vyxeos is used when the leukaemia was caused by previous treatments (e.g. for other cancers) or is associated with certain changes in the bone marrow known as myelodysplasia.
Danish: Vyxeos anvendes, når leukæmien skyldes tidligere terapier (f.eks. til behandling af andre kræftsygdomme) eller er forbundet med forandringer i knoglemarven, der kaldes myelodysplasi.
English: For the full list of side effects and restrictions with Vyxeos, see the package leaflet.
Danish: Den fuldstændige liste over bivirkninger og begrænsninger ved Vyxeos fremgår af indlægssedlen.
English: The active substances in Vyxeos are daunorubicin and cytarabine.
Danish: De aktive stoffer i Vyxeos er daunorubicin og cytarabin.
English: How does Vyxeos work?
Danish: Hvordan virker Vyxeos?
English: What benefits of Vyxeos have been shown in studies?
Danish: Hvilke fordele viser studierne, at der er ved Vyxeos?
English: Vyxeos is a cancer medicine used to treat adults with newly diagnosed acute myeloid leukaemia, a cancer of white blood cells.
Danish: Vyxeos anvendes til at behandle patienter med nydiagnosticeret akut myeloid leukæmi, en form for kræft i de hvide blodlegemer.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Vyxeos have been included in the summary of product characteristics and the package leaflet.
Danish: Der er anført anbefalinger og forholdsregler i produktresuméet og indlægssedlen, som patienter og sundhedspersonale skal følge for at sikre risikofri og effektiv anvendelse af Vyxeos.
English: How is Vyxeos used?
Danish: Hvordan anvendes Vyxeos?
English: The dose is calculated based on the patient's height and weight; the infusion is given over 90 minutes on days 1, 3 and 5 of an initial treatment course; if the disease responds and the doctor considers further courses would be of benefit, Vyxeos is given on days 1 and 3 of each further course.
Danish: Infusionen indgives over 90 minutter dag 1, 3 og 5 i en første behandlingsserie.
English: Vyxeos improved survival compared with conventional cytarabine and daunorubicin in patients with acute myeloid leukaemia who have a poor prognosis and few alternatives.
Danish: Vyxeos forbedrede overlevelsen hos patienter med akut myeloid leukæmi, der havde en dårlig prognose og kun få andre behandlingsmuligheder, sammenholdt med konventionel cytarabin og daunorubicin.
English: Vyxeos has been shown to improve how long patients lived in one main study involving 309 patients with high-risk acute myeloid leukaemia linked to previous treatment or associated with myelodysplasia.
Danish: I et hovedstudie af 309 højrisikopatienter med akut myeloid leukæmi, der var relateret til tidligere behandling eller forbundet med myelodysplasi, blev det påvist, at Vyxeos forlænger patienternes levetid.
English: United Kingdom Cipla (Eu) Limited
Danish: Storbritannien Cipla (Eu) Limited
English: United Kingdom Pfizer Limited
Danish: Storbritannien Pfizer Limited
English: Medicus A.E
Danish: Grækenland Medicus A.E
English: Norway
Danish: Norge
English: Chemipharm S.G. De Tchaves & Cie E.E
Danish: De Tchaves & Cie E.E
English: United Kingdom Orion Corporation
Danish: Storbritannien Orion Corporation
English: Bulgaria
Danish: Bulgarien
English: Injection
Danish: Injektion
English: Estonia
Danish: Estland
English: Belgium Teva Pharma Belgium N.V./S.A
Danish: Teva Pharma Belgium N.V./S.A
English: S.C. Rompharm Company S.R.L.
Danish: Rumænien S.C. Rompharm Company S.R.L.
English: Intravenous Use
Danish: Intravenøs anvendelse
English: Cyprus
Danish: Cypern
English: Latvia
Danish: Letland
English: Ireland
Danish: Irland
English: Oral Solution
Danish: Oral anvendelse
English: Germany
Danish: Tyskland
English: United Kingdom Rosemont Pharmaceuticals Limited
Danish: Storbritannien Rosemont Pharmaceuticals Limited
English: France
Danish: Frankrig
English: United Kingdom Hameln Pharmaceuticals Ltd Methotrexate Hameln
Danish: Storbritannien Hameln Pharmaceuticals Ltd Methotrexate Hameln
English: Netherlands Teva Nederland B.V.
Danish: Teva Nederland B.V.
English: Belgium Pfizer S.A. (Belgium)
Danish: Pfizer S.A. (Belgium)
English: United Kingdom Nordic Group B.V.
Danish: Storbritannien Nordic Group B.V.
English: Italy
Danish: Italien
English: United Kingdom Hospira Uk Ltd
Danish: Storbritannien Hospira Uk Ltd
English: Belgium Aurobindo Pharma B.V.
Danish: Aurobindo Pharma B.V.
English: Austria
Danish: Østrig
English: Poland
Danish: Polen
English: Iceland
Danish: Island
English: Sweden
Danish: Sverige
English: Denmark
Danish: Danmark
English: Spain
Danish: Spanien
English: Film-Coated Tablet
Danish: Filmovertrukket tablet Oral anvendelse
English: Slovakia
Danish: Slovakiet
English: Slovenia
Danish: Slovenien
English: United Kingdom Morningside Healthcare Ltd Methotrexate Morningside
Danish: Storbritannien Morningside Healthcare Ltd Methotrexate Morningside
English: United Kingdom Actavis Group Ptc Ehf.
Danish: Storbritannien Actavis Group Ptc Ehf.
English: Belgium Sandoz N.V.
Danish: Sandoz N.V.
English: Hungary
Danish: Ungarn
English: Croatia
Danish: Kroatien
English: Injection/Infusion
Danish: Injektions/infusionsvæske, opløsning
English: Netherlands Centrafarm B.V.
Danish: Centrafarm B.V.
English: United Kingdom Ebewe Pharma
Danish: Storbritannien Ebewe Pharma
English: United Kingdom Mercury Pharmaceuticals Ltd. Methotrexate Mercury
Danish: Storbritannien Mercury Pharmaceuticals Ltd. Methotrexate Mercury
English: Netherlands Mylan B.V.
Danish: Mylan B.V.
English: Methotrexat Medac Methotrexate Disodium 16.44mg/3ml
Danish: Methotrexat Medac Methotrexatdinatrium 16,44mg/3ml
English: Methotrexate 5g/50ml
Danish: Methotrexat 5g/50ml
English: Methotrexate Gry Methotrexate Disodium 1096.73mg/10ml
Danish: Methotrexate Gry Methotrexatdinatrium 1096,73mg/10ml
English: Epidural Use | Intrabursal Use | Intracoronary Use | Intradiscal Use | Intramuscular Use | Intravenous Use | Perineural Use| Retrobulbar Use
Danish: Epidural anvendelse | Intrabursal anvendelse | Intrakoronar anvendelse | Intradiskal anvendelse | Intramuskulær anvendelse | Intravenøs anvendelse | Perineural anvendelse | Retrobulbær anvendelse
English: Methotrexate Disodium 1096.8mg
Danish: Methotrexatdinatrium 1096,8mg
English: Nationally authorised medicinal products Member State in EEA
Danish: Bilag I Liste over nationalt godkendte lægemidler
English: Methotrexate Sodium 1.097g/10ml
Danish: Methotrexatnatrium 1,097g/10ml
English: Methotrexate Sodium 21.936mg/2.66ml
Danish: Methotrexatnatrium 21,936mg/2,66ml
English: Methotrexate 1g/40ml
Danish: Methotrexat 1g/40ml
English: Methotrexate Sodium 10.968mg/1.33ml
Danish: Methotrexatnatrium 10,968mg/1,33ml
English: Methotrexate Teva Methotrexate 5g/20ml
Danish: Methotrexate Teva Methotrexat 5g/20ml
English: Methotrexate Pfizer Methotrexate 1000mg/40ml
Danish: Methotrexate Pfizer Methotrexat 1000mg/40ml
English: Intravenous Use | Subcutaneous Use
Danish: Intravenøs brug | Subkutan brug
English: Methotrexate Disodium 10.96mg Tablet
Danish: Methotrexatdinatrium 10,96mg tablet
English: Methotrexate 1g/10ml
Danish: Methotrexat 1g/10ml
English: Metotrexato Teva Methotrexate 1040mg/20ml
Danish: Metotrexato Teva Methotrexat 1040mg/20ml
English: Accord Healthcare Limited Methotrexat Accord Methotrexate 10mg Tablet
Danish: Accord Healthcare Limited Methotrexat Accord Methotrexat 10mg tablet
English: Metotrexato Wyeth Methotrexate Sodium 1g/40ml
Danish: Metotrexato Wyeth Methotrexatnatrium 1g/40ml
English: Methotrexate 0.6ml/30mg
Danish: Methotrexat 0,6ml/30mg
English: Methotrexate 0.4ml/20mg
Danish: Methotrexat 0,4ml/20mg
English: Methotrexate Disodium 8.22mg Tablet
Danish: Methotrexatdinatrium 8,22mg tablet
English: Methotrexate Disodium 16.44mg Tablet
Danish: Methotrexatdinatrium 16,44mg tablet
English: Methotrexaat Teva Methotrexate 17.5mg/0.7ml
Danish: Methotrexaat Teva Methotrexat 17,5mg/0,7ml
English: Accord Healthcare Limited Инжексат Accord Methotrexate 15mg/0.3ml
Danish: Accord Healthcare Limited Инжексат Accord Methotrexat 15mg/0,3ml
English: Metotreksat Pliva Methotrexate 1000mg/10ml
Danish: Metotreksat Pliva Methotrexat 1000mg/10ml
English: Metotreksat Pliva Methotrexate 2.5mg/Ml
Danish: Metotreksat Pliva Methotrexat 2,5mg/ml
English: United Kingdom Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)
Danish: Storbritannien Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)
English: Methotrexate Disodium 27.41mg/Ml
Danish: Methotrexatdinatrium 27,41mg/ml
English: Methotrexaat Teva Methotrexate 20mg/0.8ml
Danish: Methotrexaat Teva Methotrexat 20mg/0,8ml
English: Methotrexate Disodium 16.44mg/0.6ml
Danish: Methotrexatdinatrium 16,44mg/0,6ml
English: Metotrexato Accord Methotrexate 1000mg/40ml
Danish: Metotrexato Accord Methotrexat 1000mg/40ml
English: Netherlands Sandoz B.V.
Danish: Sandoz B.V.
English: Methotrexate Teva Methotrexate 2.5mg Tablet
Danish: Methotrexate Teva Methotrexat 2,5mg tablet
English: United Kingdom Accord Healthcare Limited Methofill
Danish: Storbritannien Accord Healthcare Limited Methofill
English: Metotrexato Wyeth Methotrexate 2.5mg Tablet
Danish: Metotrexato Wyeth Methotrexat 2,5mg tablet
English: Methotrexate 0.2ml/10mg
Danish: Methotrexat 0,2ml/10mg
English: Methotrexaat Teva Methotrexate 15mg/0.6ml
Danish: Methotrexaat Teva Methotrexat 15mg/0,6ml
English: Methotrexate Sodium 16.452mg/2ml
Danish: Methotrexatnatrium 16,452mg/2ml
English: Powder For Solution For Injection
Danish: Pulver til injektionsvæske, opløsning
English: Methotrexaat Teva Methotrexate 20mg Syringe
Danish: Methotrexaat Teva Methotrexat 20mg injektionssprøjte
English: Methotrexate Disodium 2.19mg/Ml
Danish: Methotrexatdinatrium 2,19mg/ml
English: Methotrexate 0.45ml/22.5mg
Danish: Methotrexat 0,45ml/22,5mg
English: Metotreksat Cipla Methotrexate 10mg Tablet
Danish: Metotreksat Cipla Methotrexat 10mg tablet
English: Metotrexato Pfizer Methotrexate 500mg Bottle
Danish: Metotrexato Pfizer Methotrexat 500mg flaske
English: Methotrexaat Teva Methotrexate 15mg Syringe
Danish: Methotrexaat Teva Methotrexat 15mg injektionssprøjte
English: Methotrexate 0.15ml/7.5mg
Danish: Methotrexat 0,15ml/7,5mg
English: Metotrexato Accord Methotrexate 500mg/20ml
Danish: Metotrexato Accord Methotrexat 500mg/20ml
English: Methotrexate Orion Methotrexate 10mg Tablet
Danish: Methotrexate Orion Methotrexat 10mg tablet
English: Methotrexaat Teva Methotrexate 10mg/0.4ml
Danish: Methotrexaat Teva Methotrexat 10mg/0,4ml
English: Metotrexato Accord Methotrexate 50mg/2ml
Danish: Metotrexato Accord Methotrexat 50mg/2ml
English: Methotrexate 0.3ml/15mg
Danish: Methotrexat 0,3ml/15mg
English: Метожект Pen Methotrexate 30mg/0.6ml
Danish: Метожект Pen Methotrexat 30mg/0,6ml
English: Methotrexate Orion Methotrexate 25mg Tablet
Danish: Methotrexate Orion Methotrexat 25mg tablet
English: Metotrexato Accord Methotrexate 5000mg/50ml
Danish: Metotrexato Accord Methotrexat 5000mg/50ml
English: Methotrexate Disodium 21.92mg/0.8ml
Danish: Methotrexatdinatrium 21,92mg/0,8ml
English: Methotrexaat Teva Methotrexate 22.5mg/0.9ml
Danish: Methotrexaat Teva Methotrexat 22,5mg/0,9ml
English: Methotrexate 0.35ml/17.5mg
Danish: Methotrexat 0,35ml/17,5mg
English: Metotrexat Medac Methotrexate 50mg/Ml
Danish: Metotrexat Medac Methotrexat 50mg/ml
English: Netherlands Teva Pharma B.V.
Danish: Teva Pharma B.V.
English: Methotrexate Disodium 10.96mg/0.4ml
Danish: Methotrexatdinatrium 10,96mg/0,4ml
English: Methotrexate Sodium 5.484g/50ml
Danish: Methotrexatnatrium 5,484g/50ml
English: Methotrexate Disodium 5.48mg Tablet
Danish: Methotrexatdinatrium 5,48mg tablet
English: Метожект Pen Methotrexate 20mg/0.4ml
Danish: Метожект Pen Methotrexat 20mg/0,4ml
English: Methotrexate Orion Methotrexate 25mg/Ml
Danish: Methotrexate Orion Methotrexat 25mg/ml
English: Methotrexate Sodium 1.097g Vial
Danish: Methotrexatnatrium 1,097g hætteglas
English: Metotreksat Pliva Methotrexate 50mg/2ml
Danish: Metotreksat Pliva Methotrexat 50mg/2ml
English: Methotrexaat Pch Methotrexate 10mg Tablet
Danish: Methotrexaat Pch Methotrexat 10mg tablet
English: Methotrexate Disodium 5483.7mg
Danish: Methotrexatdinatrium 5483,7mg
English: Methotrexate Disodium 10.97mg/Ml
Danish: Methotrexatdinatrium 10,97mg/ml
English: Metotreksat Ebewe Methotrexate Disodium 21.94mg/Ml
Danish: Metotreksat Ebewe Methotrexatdinatrium 21,94mg/ml
English: Methotrexate 0.25ml/12.5mg
Danish: Methotrexat 0,25ml/12,5mg
English: Methotrexat Ebewe Methotrexate Disodium 10.97mg/Ml
Danish: Methotrexat Ebewe Methotrexatdinatrium 10,97mg/ml
English: Methotrexaat Teva Methotrexate 25mg Syringe
Danish: Methotrexaat Teva Methotrexat 25mg injektionssprøjte
English: Metotrexato Accord Methotrexate 500mg/5ml
Danish: Metotrexato Accord Methotrexat 500mg/5ml
English: Methotrexate Teva Methotrexate 1000mg/10ml
Danish: Methotrexate Teva Methotrexat 1000mg/10ml
English: Metotrexato Wyeth Methotrexate Sodium 5g/200ml
Danish: Metotrexato Wyeth Methotrexatnatrium 5g/200ml
English: Метожект Pen Methotrexate 22.5mg/0.45ml
Danish: Метожект Pen Methotrexat 22,5mg/0,45ml
English: Метожект Pen Methotrexate 10mg/0.2ml
Danish: Метожект Pen Methotrexat 10mg/0,2ml
English: Methotrexate Cipla Methotrexate 10mg Tablet
Danish: Methotrexate Cipla Methotrexat 10mg tablet
English: Methotrexate 17.5mg Syringe
Danish: Methotrexat 17,5mg injektionssprøjte
English: Belgium Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)
Danish: Grækenland Medac Gesellschaft Für Klinische Spezialpräparate Mbh (Wedel)
English: Methotrexaat Teva Methotrexate 7.5mg/0.3ml
Danish: Methotrexaat Teva Methotrexat 7,5mg/0,3ml
English: Metotrexato Accord Methotrexate 1000mg/10ml
Danish: Metotrexato Accord Methotrexat 1000mg/10ml
English: Methotrexaat Teva Methotrexate 12.5mg/0.5ml
Danish: Methotrexaat Teva Methotrexat 12,5mg/0,5ml
English: Metotreksat Ebewe Methotrexate 20mg/Ml
Danish: Metotreksat Ebewe Methotrexat 20mg/ml
English: Metotrexat Astron Methotrexate 30mg/0.6ml
Danish: Metotrexat Astron Methotrexat 30mg/0,6ml
English: Метожект Pen Methotrexate 12.5mg/0.25ml
Danish: Метожект Pen Methotrexat 12,5mg/0,25ml
English: Methotrexate 10mg Tablet
Danish: Methotrexat 10mg tablet
English: Metotrexato Mylan Methotrexate 25mg/Ml
Danish: Metotrexato Mylan Methotrexat 25mg/ml
English: Methotrexate Disodium 2.74mg Tablet
Danish: Methotrexatdinatrium 2,74mg tablet
English: Metotrexato Wyeth Methotrexate Sodium 500mg/20ml
Danish: Metotrexato Wyeth Methotrexatnatrium 500mg/20ml
English: Methotrexat Ebewe Methotrexate Disodium 21.94mg/Ml
Danish: Methotrexat Ebewe Methotrexatdinatrium 21,94mg/ml
English: Methotrexat Stada Methotrexate 25mg/Ml
Danish: Methotrexat Stada Methotrexat 25mg/ml